ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (OTCBB:BTIM) and the International Longevity Center-USA today announced a collaboration aimed at research, education and advocacy for regenerative medicine and its application in aging. Founded by President and CEO, Robert N. Butler, M.D. in 1990, the International Longevity Center is a non-profit international research, policy, and education organization formed to educate individuals on how to live longer and better, and advise society on how to maximize the benefits of technology, such as the emerging field of regenerative medicine for today's age boom. BioTime is a biotechnology company developing human embryonic stem cell research and induced pluripotent stem cell (“iPS”) products from human embryonic stem cells and iPS technology potentially useful in restoring function in tissues afflicted with age-related degenerative disease.
